Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 4439 | 0.75 |
09:34 ET | 2166 | 0.75 |
09:36 ET | 21323 | 0.73 |
09:38 ET | 350 | 0.738749 |
09:39 ET | 3498 | 0.7275 |
09:41 ET | 1265 | 0.7291 |
09:43 ET | 1015 | 0.723 |
09:45 ET | 800 | 0.7287 |
09:48 ET | 400 | 0.723 |
09:50 ET | 200 | 0.7261 |
09:52 ET | 5700 | 0.72435 |
09:56 ET | 500 | 0.724138 |
09:57 ET | 585 | 0.7201 |
09:59 ET | 8071 | 0.71 |
10:01 ET | 699 | 0.71 |
10:03 ET | 2756 | 0.713 |
10:06 ET | 880 | 0.71 |
10:08 ET | 5284 | 0.71 |
10:12 ET | 2248 | 0.7199 |
10:14 ET | 100 | 0.715 |
10:15 ET | 239 | 0.714 |
10:17 ET | 700 | 0.71895 |
10:19 ET | 8336 | 0.7198 |
10:21 ET | 2100 | 0.7199 |
10:24 ET | 2348 | 0.7173 |
10:26 ET | 400 | 0.7186 |
10:28 ET | 327 | 0.7174 |
10:30 ET | 1272 | 0.71834 |
10:32 ET | 400 | 0.7173 |
10:33 ET | 4614 | 0.7298 |
10:37 ET | 200 | 0.7298 |
10:48 ET | 208 | 0.7297 |
10:50 ET | 4970 | 0.7325 |
10:51 ET | 598 | 0.725 |
10:53 ET | 950 | 0.725 |
10:55 ET | 2743 | 0.7251 |
10:57 ET | 338 | 0.725 |
11:11 ET | 200 | 0.7361 |
11:13 ET | 100 | 0.725 |
11:15 ET | 1664 | 0.725 |
11:18 ET | 400 | 0.725 |
11:20 ET | 100 | 0.74 |
11:22 ET | 200 | 0.73 |
11:24 ET | 200 | 0.73 |
11:27 ET | 100 | 0.73 |
11:29 ET | 100 | 0.7399 |
11:33 ET | 200 | 0.7301 |
11:36 ET | 500 | 0.7399 |
11:38 ET | 200 | 0.73 |
11:42 ET | 100 | 0.7396 |
11:44 ET | 1500 | 0.73 |
11:45 ET | 386 | 0.73 |
11:47 ET | 900 | 0.73 |
11:49 ET | 200 | 0.7398 |
11:51 ET | 100 | 0.7397 |
11:54 ET | 620 | 0.73 |
11:58 ET | 1300 | 0.7399 |
12:00 ET | 200 | 0.730099 |
12:02 ET | 593 | 0.73 |
12:03 ET | 300 | 0.7398 |
12:05 ET | 100 | 0.73 |
12:07 ET | 100 | 0.7399 |
12:12 ET | 44797 | 0.7031 |
12:14 ET | 3742 | 0.71 |
12:16 ET | 14403 | 0.71 |
12:18 ET | 142 | 0.711299 |
12:20 ET | 300 | 0.7032 |
12:21 ET | 100 | 0.710101 |
12:23 ET | 600 | 0.7103 |
12:25 ET | 2093 | 0.7102 |
12:27 ET | 1600 | 0.7195 |
12:30 ET | 2200 | 0.7102 |
12:32 ET | 500 | 0.715301 |
12:34 ET | 400 | 0.7153 |
12:36 ET | 900 | 0.7196 |
12:38 ET | 2591 | 0.7289 |
12:39 ET | 100 | 0.7289 |
12:41 ET | 100 | 0.7289 |
12:43 ET | 142 | 0.719951 |
12:45 ET | 242 | 0.7289 |
12:48 ET | 209 | 0.71995 |
12:50 ET | 200 | 0.7112 |
12:56 ET | 1022 | 0.711 |
12:59 ET | 100 | 0.71995 |
01:01 ET | 100 | 0.7115 |
01:06 ET | 1250 | 0.7111 |
01:08 ET | 100 | 0.7115 |
01:10 ET | 500 | 0.72 |
01:12 ET | 100 | 0.72 |
01:15 ET | 100 | 0.7111 |
01:17 ET | 5900 | 0.7289 |
01:19 ET | 2800 | 0.715 |
01:24 ET | 7400 | 0.715 |
01:26 ET | 900 | 0.715 |
01:28 ET | 200 | 0.715 |
01:32 ET | 100 | 0.72195 |
01:37 ET | 550 | 0.7226 |
01:39 ET | 100 | 0.7163 |
01:42 ET | 1500 | 0.7163 |
01:44 ET | 234 | 0.7164 |
01:50 ET | 100 | 0.7163 |
01:51 ET | 173 | 0.7164 |
01:53 ET | 200 | 0.7163 |
01:55 ET | 1672 | 0.7226 |
02:04 ET | 6327 | 0.7163 |
02:11 ET | 400 | 0.7164 |
02:13 ET | 296 | 0.7164 |
02:15 ET | 135 | 0.7289 |
02:18 ET | 239 | 0.72265 |
02:24 ET | 566 | 0.72265 |
02:27 ET | 205 | 0.7216 |
02:31 ET | 100 | 0.7164 |
02:40 ET | 1100 | 0.7164 |
02:44 ET | 100 | 0.7164 |
02:49 ET | 200 | 0.7164 |
02:54 ET | 1183 | 0.7164 |
02:56 ET | 2262 | 0.7111 |
03:02 ET | 1100 | 0.715 |
03:03 ET | 600 | 0.7125 |
03:05 ET | 100 | 0.7111 |
03:09 ET | 700 | 0.7111 |
03:12 ET | 300 | 0.7111 |
03:18 ET | 100 | 0.7111 |
03:20 ET | 12589 | 0.715 |
03:21 ET | 1300 | 0.7155 |
03:23 ET | 4928 | 0.713 |
03:25 ET | 100 | 0.711 |
03:27 ET | 20981 | 0.7109 |
03:36 ET | 400 | 0.7109 |
03:38 ET | 5900 | 0.7151 |
03:39 ET | 300 | 0.7192 |
03:41 ET | 187 | 0.7166 |
03:48 ET | 919 | 0.7169 |
03:50 ET | 100 | 0.7169 |
03:54 ET | 1400 | 0.7207 |
03:56 ET | 600 | 0.7165 |
03:59 ET | 10405 | 0.7236 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 39.6M | -0.3x | --- |
ImmuCell Corp | 42.8M | -7.3x | --- |
Aadi Bioscience Inc | 46.2M | -0.7x | --- |
Turnstone Biologics Corp | 66.4M | -1.1x | --- |
Prenetics Global Ltd | 73.7M | -1.3x | --- |
SQZ Biotechnologies Co | 619.3K | 0.0x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $39.6M |
---|---|
Revenue (TTM) | $16.9M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.81 |
EPS | $-2.26 |
Book Value | $1.05 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -729.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.